Screener
Gyre Therapeutics, Inc. GYRE Net debt
Discontinued — last reported Q2 '26
Net debt at other companies
Other financials
Where this comes from
Calculated from Gyre Therapeutics, Inc.’s reported figures.
The source filing: Gyre Therapeutics, Inc.’s 10-Q, filed August 7, 2026. Open the filing →
- Filed
- Aug 7, 2026, 5:00 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001193125-26-340448
FAQ
- What is Gyre Therapeutics, Inc.'s net debt?
- Gyre Therapeutics, Inc. (GYRE) reported net debt of -$39.87M in Q2 2026.
- How has Gyre Therapeutics, Inc.'s net debt changed year-over-year?
- Gyre Therapeutics, Inc.'s net debt decreased by 13.6% year-over-year, from -$35.1M to -$39.87M.
- What is the long-term trend for Gyre Therapeutics, Inc.'s net debt?
- Over 5 years (2020 to 2025), Gyre Therapeutics, Inc.'s net debt has grown at a 10.9% compound annual growth rate (CAGR), from -$28.72M to -$48.25M.
- What does net debt mean?
- Total debt minus cash and equivalents at the quarter end. The debt that would remain if the company used all its cash to pay down borrowings.
Ask your AI about Gyre Therapeutics, Inc.'s net debt.
Connect your AI assistant and see it in context, right in your chat.
Connect your AI
Claude